home Apparatus

New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu

  • Nov 24, 2024

Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!

  • Nov 23, 2024

Two-Drug Combination For Refractory Thyroid Cancer, 100% Effective!

  • Nov 22, 2024

Two-Drug Combination For Specific Mutation Colorectal Cancer With 100% Efficiency!

  • Nov 21, 2024

Pre-Operative Immunotherapy And More Than Half Of The Tumours In This Type Of Skin Cancer Disappear Completely!

  • Nov 20, 2024

Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy!

  • Nov 19, 2024

New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!

  • Nov 18, 2024

FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!

  • Nov 17, 2024

Ovarian Cancer Heavyweight Cutting-Edge ADC Drug Elahere Proven Safe And Effective

  • Nov 16, 2024

Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer!

  • Nov 15, 2024